Find Drugs for Infections and Infectious Diseases in Phase I Clinical Development in UNITED KINGDOM

Lead Product(s): Set-point vaccines

Therapeutic Area: Infections and Infectious Diseases

Highest Development Status: Phase I Product Type: Vaccine

Partner/Sponsor/Collaborator: Vickers Venture Partners

Deal Size: $11.0 million Upfront Cash: Undisclosed

Deal Type: Series A Financing January 09, 2020

Details:

The financing will support a first-in-man Phase I clinical trial of its Flavivirus (Dengue) vaccine in Switzerland, as well as Phase Ib clinical trials in the endemic regions of Singapore and Brazil.